标题
Progress in EBV Vaccines
作者
关键词
-
出版物
Frontiers in Oncology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-02-25
DOI
10.3389/fonc.2019.00104
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Epstein–Barr virus strain heterogeneity impairs human T-cell immunity
- (2018) Ana Cirac et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus
- (2018) Joost Snijder et al. IMMUNITY
- Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma
- (2018) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo
- (2018) Viktor Schneidt et al. LEUKEMIA
- Translational profiling of B cells infected with the Epstein-Barr virus reveals 5′ leader ribosome recruitment through upstream open reading frames
- (2018) Maja Bencun et al. NUCLEIC ACIDS RESEARCH
- Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry
- (2018) Hua Zhang et al. Nature Microbiology
- Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus
- (2018) Jia Chen et al. Nature Microbiology
- Epstein–Barr Virus and Cancer
- (2018) Paul J. Farrell Annual Review of Pathology-Mechanisms of Disease
- Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice
- (2018) Dwain G. van Zyl et al. PLoS Pathogens
- Antibody-Dependent NK Cell Activation Differentially Targets EBV-Infected Cells in Lytic Cycle and Bystander B Lymphocytes Bound to Viral Antigen–Containing Particles
- (2017) María López-Montañés et al. JOURNAL OF IMMUNOLOGY
- Epstein-Barr Virus Type 2 Infects T Cells in Healthy Kenyan Children
- (2017) Carrie B Coleman et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains
- (2017) Yanping Zhang et al. VACCINE
- Epstein–Barr virus particles induce centrosome amplification and chromosomal instability
- (2017) Anatoliy Shumilov et al. Nature Communications
- Marek’s disease herpesvirus vaccines integrate into chicken host chromosomes yet lack a virus-host phenotype associated with oncogenic transformation
- (2016) Marla C. McPherson et al. VACCINE
- Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350
- (2016) Xinle Cui et al. VACCINE
- Structural basis for Epstein–Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins
- (2016) Karthik Sathiyamoorthy et al. Nature Communications
- Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice
- (2016) Elizabeth M. Perez et al. Oncotarget
- Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
- (2016) Jill M. Brooks et al. PLoS Pathogens
- Self-assembling protein nanoparticles in the design of vaccines
- (2016) Jacinto López-Sagaseta et al. Computational and Structural Biotechnology Journal
- The Immunology of Epstein-Barr Virus–Induced Disease
- (2015) Graham S. Taylor et al. Annual Review of Immunology
- Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells
- (2015) X. Yu et al. BLOOD
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
- (2015) Masaru Kanekiyo et al. CELL
- A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
- (2015) Javier Ogembo et al. Journal of Translational Medicine
- To Be or Not IIb: A Multi-Step Process for Epstein-Barr Virus Latency Establishment and Consequences for B Cell Tumorigenesis
- (2015) Alexander M. Price et al. PLoS Pathogens
- Varicella zoster virus infection
- (2015) Anne A. Gershon et al. Nature Reviews Disease Primers
- A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
- (2014) G. S. Taylor et al. CLINICAL CANCER RESEARCH
- Epstein-Barr Virus Type 2 Latently Infects T Cells, Inducing an Atypical Activation Characterized by Expression of Lymphotactic Cytokines
- (2014) Carrie B. Coleman et al. JOURNAL OF VIROLOGY
- Efficient replication of Epstein–Barr virus in stratified epithelium in vitro
- (2014) Rachel M. Temple et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assembly and Architecture of the EBV B Cell Entry Triggering Complex
- (2014) Karthik Sathiyamoorthy et al. PLoS Pathogens
- Epstein-Barr virus and nasopharyngeal carcinoma
- (2014) Lawrence S. Young et al. Chinese Journal of Cancer
- Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disorder
- (2013) M. Green et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
- (2013) E. P. Hui et al. CANCER RESEARCH
- Detection of Epstein-Barr virus-specific memory CD4+T cells using a peptide-based cultured enzyme-linked immunospot assay
- (2013) Sandra A. Calarota et al. IMMUNOLOGY
- Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
- (2013) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- CD8+ T Cell Responses to Lytic EBV Infection: Late Antigen Specificities as Subdominant Components of the Total Response
- (2013) R. J. M. Abbott et al. JOURNAL OF IMMUNOLOGY
- A novel tetrameric gp3501–470 as a potential Epstein–Barr virus vaccine
- (2013) Xinle Cui et al. VACCINE
- Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
- (2013) Javier G. Ogembo et al. Cell Reports
- An Atlas of the Epstein-Barr Virus Transcriptome and Epigenome Reveals Host-Virus Regulatory Interactions
- (2012) Aaron Arvey et al. Cell Host & Microbe
- Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
- (2012) Vanya Icheva et al. JOURNAL OF CLINICAL ONCOLOGY
- Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein–Barr Virus Infection in University Students
- (2012) Henry H. Balfour et al. JOURNAL OF INFECTIOUS DISEASES
- An Epstein-Barr Virus Mutant Produces Immunogenic Defective Particles Devoid of Viral DNA
- (2012) S. Pavlova et al. JOURNAL OF VIROLOGY
- Epstein-Barr Virus Infection of Naïve B Cells In Vitro Frequently Selects Clones with Mutated Immunoglobulin Genotypes: Implications for Virus Biology
- (2012) Emily Heath et al. PLoS Pathogens
- The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination
- (2012) Simon Jochum et al. PLoS Pathogens
- A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
- (2011) W. K. Chia et al. ANNALS OF ONCOLOGY
- Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle Recognition
- (2011) H. M. Long et al. JOURNAL OF IMMUNOLOGY
- Fusion of Epstein-Barr Virus with Epithelial Cells Can Be Triggered by v 5 in Addition to v 6 and v 8, and Integrin Binding Triggers a Conformational Change in Glycoproteins gHgL
- (2011) L. S. Chesnokova et al. JOURNAL OF VIROLOGY
- A Virus-Like Particle-Based Epstein-Barr Virus Vaccine
- (2011) R. Ruiss et al. JOURNAL OF VIROLOGY
- Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
- (2011) J. I. Cohen et al. Science Translational Medicine
- A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas
- (2010) S.-D. Ma et al. JOURNAL OF VIROLOGY
- An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
- (2010) Adam E. Handel et al. PLoS One
- Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
- (2009) Till Strowig et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T Cell–Mediated Control of Epstein‐Barr Virus Infection in Humanized Mice
- (2009) Misako Yajima et al. JOURNAL OF INFECTIOUS DISEASES
- Primary B-Cell Infection with a BALF4 Epstein-Barr Virus Comes to a Halt in the Endosomal Compartment yet Still Elicits a Potent CD4-Positive Cytotoxic T-Cell Response
- (2009) B. Neuhierl et al. JOURNAL OF VIROLOGY
- AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome
- (2009) M. Kalla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins v 6 or v 8
- (2009) L. S. Chesnokova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation
- (2009) Lesley Rees et al. TRANSPLANTATION
- EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells
- (2009) Jianqiao Xiao et al. VIROLOGY
- Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
- (2008) C. Gurer et al. BLOOD
- Risk of Herpes Zoster in Adults Immunized with Varicella Vaccine
- (2008) Sophie Hambleton et al. JOURNAL OF INFECTIOUS DISEASES
- A New Humanized Mouse Model of Epstein‐Barr Virus Infection That Reproduces Persistent Infection, Lymphoproliferative Disorder, and Cell‐Mediated and Humoral Immune Responses
- (2008) Misako Yajima et al. JOURNAL OF INFECTIOUS DISEASES
- Standardized and Highly Efficient Expansion of Epstein-Barr Virus-Specific CD4+ T Cells by Using Virus-Like Particles
- (2008) D. Adhikary et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started